Home › HTG Expands Collaboration With Merck KGaA

HTG Expands Collaboration With Merck KGaA

Dec 27, 2017

NEW YORK (GenomeWeb) – HTG Molecular Diagnostics said on Tuesday that it has signed a master new collaboration agreement with Merck KGaA, complementing an existing companion diagnostic agreement between the two companies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
05
Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

What's Popular?

In Molecular Diagnostics

  1. Liquid Biopsy IDs More NSCLC Mutations, Yields Patient Therapy Response in Study of Guardant Test

  2. Roche Patent Invalidation Affirmed in TB Testing Lawsuit Against Cepheid

  3. AmoyDx Lung Cancer CDx Approved in South Korea

  4. FDA Approves Progenika MDx Assay for Blood Compatibility

  5. Antibiotic Resistance Monitoring Consortium Expands to Highlight Battle Against Superbugs

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.